Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 1

Status

Completed 4Terminated 1

Sponsor Class

INDUSTRY 5OTHER 3NETWORK 1INDIV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 2Breast 2Head & Neck 1

Conditions

Breast Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Colorectal Neoplasms 1

Interventions

pembrolizumab 1019Carboplatin 959Paclitaxel 932Gemcitabine 793Cisplatin 748Docetaxel 682Bevacizumab 610Pemetrexed 502Nivolumab 486Cyclophosphamide 466Capecitabine 461Fluorouracil 417Dexamethasone 402Rituximab 372Oxaliplatin 347Injections 342atezolizumab 297Trastuzumab 297Leucovorin 286Cetuximab 282Irinotecan 266130-nm albumin-bound paclitaxel 252Prednisone 244Doxorubicin 240Ipilimumab 226Lenalidomide 220Fulvestrant 217fludarabine 214durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Uracil × Clear all
NCT01720563 2025-06-04

A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy

PhytoHealth Corporation

Phase 2 Terminated
17 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00152178 2011-07-07

The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
680 enrolled
Breast

Breast Neoplasms

NCT00152191 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
1,300 enrolled
Breast

Breast Neoplasms

NCT00152230 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
900 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00152243 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
500 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡